Palvella Therapeutics, Inc. SEC filings PVLA
Palvella Therapeutics, Inc. has 816 filings in SEC EDGAR's recent list, going back to Aug 20, 2013. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 5, 2026 | Nov 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 28, 2026 | — |
| 8-K |
Current report
Other events
|
Oct 28, 2026 | Oct 28, 2026 |
| 4 | Insider transaction | Oct 23, 2026 | Oct 21, 2026 |
| 144 | Notice of proposed sale | Oct 21, 2026 | — |
| 4 | Insider transaction | Oct 14, 2026 | Oct 12, 2026 |
| 144 | Notice of proposed sale | Oct 13, 2026 | — |
| 4 | Insider transaction | Sep 18, 2026 | Sep 16, 2026 |
| 144 | Notice of proposed sale | Sep 16, 2026 | — |
| 4 | Insider transaction | Sep 15, 2026 | Sep 11, 2026 |
| 144 | Notice of proposed sale | Sep 11, 2026 | — |
| 4 | Insider transaction | Sep 4, 2026 | Sep 2, 2026 |
| 144 | Notice of proposed sale | Sep 2, 2026 | — |
| 4 | Insider transaction | Aug 20, 2026 | Aug 19, 2026 |
| 144 | Notice of proposed sale | Aug 19, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 10, 2026 | — |
| S-8 | Employee stock plan registration | Aug 4, 2026 | — |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 4, 2026 | Aug 4, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 3, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 29, 2026 | — |
| 4 | Insider transaction | Jul 17, 2026 | Jul 15, 2026 |
| 144 | Notice of proposed sale | Jul 15, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 14, 2026 | Jul 14, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 3 | Initial insider ownership | Jul 1, 2026 | Jun 29, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 30, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 17, 2026 |
| 144 | Notice of proposed sale | Jun 17, 2026 | — |
| 4 | Insider transaction | Jun 16, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 16, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | May 22, 2026 | May 20, 2026 |
| 144 | Notice of proposed sale | May 20, 2026 | — |
| 8-K |
Current report
Other events
|
May 20, 2026 | May 20, 2026 |
| 8-K |
Current report
Other events
|
May 15, 2026 | May 15, 2026 |
| 8-K |
Current report
Other events
|
May 13, 2026 | May 11, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Apr 17, 2026 | Apr 15, 2026 |
| 4 | Insider transaction | Apr 15, 2026 | Apr 13, 2026 |
| 3 | Initial insider ownership | Apr 15, 2026 | Apr 13, 2026 |
| 144 | Notice of proposed sale | Apr 15, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Apr 13, 2026 | Apr 13, 2026 |
| 8-K |
Current report
Other events
|
Apr 7, 2026 | Apr 7, 2026 |
| 4 | Insider transaction | Apr 1, 2026 | Mar 30, 2026 |
| 10-K | Annual report | Mar 31, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 31, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Mar 20, 2026 | Mar 18, 2026 |
| 144 | Notice of proposed sale | Mar 18, 2026 | — |
| 4 | Insider transaction | Mar 2, 2026 | Feb 27, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 27, 2026 |
| 8-K |
Current report
Material agreement
|
Feb 26, 2026 | Feb 25, 2026 |
| 424B5 | Prospectus supplement | Feb 26, 2026 | — |
| 424B5 | Prospectus supplement | Feb 24, 2026 | — |
| 8-K |
Current report
Results of operations
|
Feb 24, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 24, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Other events
|
Feb 24, 2026 | Feb 24, 2026 |
| 4 | Insider transaction | Feb 20, 2026 | Feb 18, 2026 |
| 144/A | Filing | Feb 19, 2026 | — |
| 144 | Notice of proposed sale | Feb 18, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 9, 2026 | Feb 5, 2026 |
| EFFECT | Filing | Jan 29, 2026 | — |
| 8-K |
Current report
Other events
|
Jan 29, 2026 | Jan 29, 2026 |
| CORRESP | Letter to the SEC | Jan 27, 2026 | — |
| 4 | Insider transaction | Jan 23, 2026 | Jan 21, 2026 |
| 144 | Notice of proposed sale | Jan 21, 2026 | — |
| 8-K |
Current report
Other events
|
Jan 12, 2026 | Jan 12, 2026 |
| UPLOAD | Letter from the SEC | Jan 5, 2026 | — |
| S-3 | Shelf registration | Jan 2, 2026 | — |
| 4 | Insider transaction | Dec 19, 2025 | Dec 17, 2025 |
| 144 | Notice of proposed sale | Dec 17, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 15, 2025 | Dec 15, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 144 | Notice of proposed sale | Nov 19, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 13, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Nov 5, 2025 | Nov 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 24, 2025 | Sep 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 3, 2025 | Sep 3, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2025 | Aug 14, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 3, 2025 | May 27, 2025 |
| 3 | Initial insider ownership | Jun 3, 2025 | May 27, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2025 | May 15, 2025 |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 10, 2025 |
| 4 | Insider transaction | Apr 10, 2025 | Apr 9, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 31, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 4, 2025 | Mar 4, 2025 |
| S-8 | Employee stock plan registration | Feb 18, 2025 | — |
| 4/A | Primary document | Feb 10, 2025 | Feb 5, 2025 |
| 4/A | Primary document | Feb 10, 2025 | Feb 5, 2025 |
| 4/A | Primary document | Feb 10, 2025 | Feb 5, 2025 |
| 4/A | Primary document | Feb 10, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 7, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 7, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 7, 2025 | Feb 5, 2025 |
| 4 | Insider transaction | Feb 7, 2025 | Feb 5, 2025 |
| 424B3 | Prospectus | Jan 17, 2025 | — |
| EFFECT | Filing | Jan 16, 2025 | — |
| CORRESP | Letter to the SEC | Jan 15, 2025 | — |
| S-1/A | Amended registration statement | Jan 14, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 8, 2025 | — |
| 3/A | Amended initial statement of beneficial ownership of securities | Jan 6, 2025 | Dec 13, 2024 |
| UPLOAD | Letter from the SEC | Jan 3, 2025 | — |
| S-1 | Registration statement | Dec 31, 2024 | — |
| SCHEDULE 13D | Ownership over 5% (active) | Dec 20, 2024 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 20, 2024 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 20, 2024 | — |
| 4 | Insider transaction | Dec 19, 2024 | Dec 18, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 17, 2024 | Dec 13, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Dec 17, 2024 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 17, 2024 | — |
| 3 | Initial insider ownership | Dec 16, 2024 | Dec 13, 2024 |
| 3 | Initial insider ownership | Dec 16, 2024 | Dec 13, 2024 |
| 3 | Initial insider ownership | Dec 16, 2024 | Dec 13, 2024 |
| 3 | Initial insider ownership | Dec 16, 2024 | Dec 13, 2024 |
| 3 | Initial insider ownership | Dec 16, 2024 | Dec 13, 2024 |
| 3 | Initial insider ownership | Dec 16, 2024 | Dec 13, 2024 |
| 3 | Initial insider ownership | Dec 16, 2024 | Dec 13, 2024 |
| 3 | Initial insider ownership | Dec 16, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 16, 2024 | Dec 13, 2024 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
|
Dec 16, 2024 | Dec 13, 2024 |
| 4 | Insider transaction | Dec 12, 2024 | Dec 12, 2024 |
| 425 | Form 425 | Dec 12, 2024 | — |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Dec 12, 2024 | Dec 11, 2024 |
| 4 | Insider transaction | Dec 9, 2024 | Dec 2, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Dec 6, 2024 | — |
| 425 | Form 425 | Dec 3, 2024 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Dec 3, 2024 | Dec 2, 2024 |
| 3 | Initial insider ownership | Nov 18, 2024 | Nov 6, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 14, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| SEC STAFF LETTER | Filing | Nov 12, 2024 | — |
| EFFECT | Filing | Nov 8, 2024 | — |
| 424B3 | Prospectus | Nov 8, 2024 | — |
| 425 | Form 425 | Nov 7, 2024 | — |
| CORRESP | Letter to the SEC | Nov 7, 2024 | — |
| S-4/A | Form s-4/a | Nov 7, 2024 | — |
| DEF 14A | Proxy statement | Nov 6, 2024 | Dec 2, 2024 |
| ARS | Annual report to shareholders | Nov 6, 2024 | Dec 31, 2023 |
| CORRESP | Letter to the SEC | Nov 5, 2024 | — |
| S-4/A | Form s-4/a | Nov 5, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 4, 2024 | — |
| CORRESP | Letter to the SEC | Oct 29, 2024 | — |
| S-4/A | Form s-4/a | Oct 29, 2024 | — |
| 4 | Insider transaction | Oct 28, 2024 | Aug 7, 2024 |
| SEC STAFF LETTER | Filing | Oct 25, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 25, 2024 | — |
| 425 | Form 425 | Oct 17, 2024 | — |
| CORRESP | Letter to the SEC | Oct 15, 2024 | — |
| S-4/A | Form s-4/a | Oct 15, 2024 | — |
| 425 | Form 425 | Oct 15, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 9, 2024 | — |
| 425 | Form 425 | Oct 3, 2024 | — |
| 8-K |
Current report
Other events
|
Oct 3, 2024 | Oct 3, 2024 |
| CORRESP | Letter to the SEC | Sep 23, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PVLA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- NV
- Headquarters
- Wayne, PA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1583648
- Former names
- PIERIS PHARMACEUTICALS, INC. (until Dec 12, 2024); Marika Inc. (until Dec 18, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.